Live tape
Top 8, mentions 7d11,502TSLA2,369 mentions▲ +0.05SPCX1,821 mentions▲ +0.08GOOGL1,601 mentions▲ +0.04CRWV1,446 mentions▲ +0.03NVDA1,232 mentions▲ +0.07QQQ1,194 mentions▲ +0.05NBIS943 mentions▲ +0.06META896 mentions▲ +0.05

Equity · Healthcare

IBRX

NASDAQ

ImmunityBio (IBRX)

$8.40 −8.70% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Oct 19, 2026

Reddit mentioned IBRX 26 times in the 30 days to 20 October 2026, across 2 of the communities we track. All of them were scored for sentiment: 58% read bullish, 8% bearish and 34% neither. Reddit data updated 20 October 2026.

Price · Chart
63 sessions
$12 $6 22 Jul 19 Oct

The line runs $7.52 on 22 July through $8.40 on 19 October, on a scale from $6 to $12. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView TradingView chart · our licensed closes: 63 sessions, 22 Jul – 19 Oct 2026
Market cap $8.9B
52-week range $1.98 – $12
Avg volume 702.4K
Mentions · 30d 26
Net sentiment +0.11

as of Oct 19, 2026

ImmunityBio (IBRX) · crowd attention × price

Share ↗
Post on X Share on Reddit Share on LinkedIn
26 mentions

Day19 Oct 2026

MENTIONS10–6 / day
PRICE$8.40$8–$11
MOOD67%FAIRLY BULLISH
IBRX over the last 30 days, plotting daily Reddit mentions as bars, left-hand scale; the daily closing price as a line on its own right-hand scale, solid across consecutive trading days, held flat and diagonally hatched over days the market was closed, diagonally hatched over days we hold no close for; the crowd's sentiment as a scattered ribbon against a dashed neutral rule — each point is the mix over the 7 days ending that day, above the rule more mentions bullish than bearish and below it the reverse — denser on days with more mentions.per day0246% bull10%30%50%70%90%usd$8$9$10$1121 Sep28 Sep6 Oct13 Oct20 Oct
IBRX over the last 30 days, plotting daily Reddit mentions as bars, left-hand scale; the daily closing price as a line on its own right-hand scale, solid across consecutive trading days, held flat and diagonally hatched over days the market was closed, diagonally hatched over days we hold no close for; the crowd's sentiment as a scattered ribbon against a dashed neutral rule — each point is the mix over the 7 days ending that day, above the rule more mentions bullish than bearish and below it the reverse — denser on days with more mentions.50% BULL21 Sep6 Oct20 Oct
The Distributed Sentinel 20 Oct 2026

IBRX drew 26 Reddit mentions over the 30 days to 20 October 2026

This chart in words

The chart plots daily Reddit mentions of IBRX over the 30 days to 20 October 2026: 26 in total, busiest on 30 September with 4, and 1 on the last day counted. The line is the daily close over the same window: $8.45 on 21 September, $8.40 on 19 October. Of those days, 21 were trading sessions and the other 9 are hatched on the chart. On 8 of them no session took place, and the last close before it is carried forward rather than plotted; on 1 of them we hold no close at all, which is a gap in our own record rather than a closure we can prove. Sentiment — the bullish share of the mentions that took a side, where the chart's dashed rule marks the 50% at which bullish and bearish are even — ran from 67% bullish to 100% bullish over the 9 days that carried enough mentions to measure. 19 days either fell under the 5-mention floor or carried no bullish or bearish mention at all, and so carry no sentiment point.

ImmunityBio (IBRX) on Reddit · 30d

n = 26 scored · Method

In the 30 days to 21 Oct 2026, ImmunityBio drew 26 Reddit mentions in the finance subreddits we track, 26 of them scored for sentiment.

IBRX

58% bullish

Overall market sentiment

54% bullish

IBRX reads 4 points more bullish than overall market sentiment. Same measure; same 30-day window.

Where IBRX is discussed

(30d)
r/wallstreetbets 92% 24 +0.11
r/stocks 8% 2 +0.14

Moves with IBRX

co-mention r · 31 obs

Tickers whose daily Reddit volume rose and fell with IBRX's. Co-discussion, not price.

EO +0.65 CORE CPI +0.60 CHPS +0.59 SKYDANCE.PRV +0.59 PHI +0.58 SI +0.56

How closely daily Reddit mention counts rose and fell together over the last 30 days (31 daily observations) · Method

ImmunityBio (IBRX) insider trades

SEC Form 4 · last 90 days · newest reported trade 5 Oct 2026

In the 90 days to 21 Oct 2026, ImmunityBio insiders reported 2 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 12 Dec 2025, show no open-market purchase.

Open-market buys 0
Open-market sells 2
Net sold $1.12M
Non-trade filings 1
Date Insider Type Shares Value
05 Oct 2026 Simon Barry J. Director Sell 25,000 $269K
02 Oct 2026 Cohen Cheryl Director Sell 81,056 $851K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
02 Oct 2026 Cohen Cheryl Director Option exercise 55,979 $167K

ImmunityBio (IBRX) reported financials

SEC EDGAR XBRL SEC EDGAR

ImmunityBio reported revenue of $113.3M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$351.4M.

Figure Reported Period
Revenue $113.3M 31 Dec 2025 fiscal year
Net income −$351.4M 31 Dec 2025 fiscal year
Diluted EPS −$0.38 31 Dec 2025 fiscal year
Total assets $628.5M 30 Jun 2026 at period end
Total equity −$1.0B 30 Jun 2026 at period end

ImmunityBio (IBRX) earnings

SEC EDGAR

ImmunityBio last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of −$0.22; no next date is announced in SEC filings yet.

Date Period EPS Revenue
30 Jun 2026 Q2 2026 −$0.22 $51M
31 Mar 2026 Q1 2026 −$0.62 $44M
31 Dec 2025 FY 2025 −$0.38 $113M
30 Sep 2025 Q3 2025 −$0.07 $32M
30 Jun 2025 Q2 2025 −$0.10 $26M
31 Mar 2025 Q1 2025 −$0.15 $17M
31 Dec 2024 FY 2024 −$0.62 $15M
30 Sep 2024 Q3 2024 −$0.14 $6M

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

ImmunityBio (IBRX) institutional holders (13F)

SEC Form 13F SEC EDGAR

8 of the 45 institutional funds we track reported a ImmunityBio position for the quarter ended 30 Jun 2026 — a combined $263.4M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
D. E. Shaw & Co. Held (±25%) −8.1% shares 11,551,019 $101.1M
Two Sigma Investments Added +153.0% shares 11,097,106 $97.2M
Millennium Management Added +292.9% shares 5,579,793 $48.9M
Renaissance Technologies New position 1,029,399 $9.0M
Marshall Wace Added +403.3% shares 387,700 $3.4M
AQR Capital Management Added +234.9% shares 222,862 $2.0M
Citadel Advisors Trimmed −55.5% shares 136,045 $1.2M
Balyasny Asset Management Held (±25%) −19.5% shares 83,584 $732K
Tudor Investment Corp Exited

ImmunityBio (IBRX) fails-to-deliver

SEC CNS data SEC

On 30 Sep 2026, 3,076 shares of ImmunityBio failed to deliver (about $27K) — the latest of 2 consecutive trading days with recorded fails.

Settlement date Shares failed Notional % of shares out
30 Sep 2026 3,076 $27K <0.001%
29 Sep 2026 3,069 $26K <0.001%
25 Sep 2026 3,549 $31K <0.001%
24 Sep 2026 13,170 $114K 0.001%
23 Sep 2026 220,335 $2.0M 0.021%
22 Sep 2026 1,883 $16K <0.001%
21 Sep 2026 190,544 $1.6M 0.018%
18 Sep 2026 96,724 $818K 0.009%
17 Sep 2026 13,051 $103K 0.001%
16 Sep 2026 9,322 $76K 0.001%
15 Sep 2026 43,526 $364K 0.004%
14 Sep 2026 3,560 $28K <0.001%
10 Sep 2026 2,942 $24K <0.001%
09 Sep 2026 2,894 $24K <0.001%

Congressional trades in ImmunityBio (IBRX)

STOCK Act disclosures House disclosures

The most recent congressional trade disclosed in ImmunityBio is a purchase by Lisa C. McClain (house, MI), dated 30 Sep 2026.

Date Member Type Amount
30 Sep 2026 filed 12 Oct 2026 Lisa C. McClain house · Republican–MI Purchase $1K–$15K
28 Sep 2026 filed 12 Oct 2026 Lisa C. McClain house · Republican–MI Purchase $1K–$15K
06 Mar 2023 filed 17 Apr 2023 Daniel S. Goldman house · Democrat–NY Sale $1K–$15K

ImmunityBio (IBRX): frequently asked questions

From live data

Have ImmunityBio insiders bought or sold shares recently?

In the 90 days to 21 Oct 2026, ImmunityBio insiders reported 2 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 12 Dec 2025, show no open-market purchase. A further 1 filing was a grant, award, gift or exercise rather than an open-market trade.

How many institutions hold ImmunityBio?

8 of the 45 institutional funds we track reported a ImmunityBio position for the quarter ended 30 Jun 2026, per SEC Form 13F filings.

Has ImmunityBio had fails-to-deliver recently?

Yes. The most recent SEC fails-to-deliver record for ImmunityBio is dated 30 Sep 2026, when 3,076 shares failed to deliver.

When did ImmunityBio last report earnings?

ImmunityBio last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of −$0.22; no next date is announced in SEC filings yet.

What exchange is ImmunityBio listed on?

ImmunityBio trades on NASDAQ under the ticker IBRX.

What is Reddit saying about ImmunityBio?

ImmunityBio was mentioned 7 times in the last 7 days across the finance subreddits we track, and 26 times over the trailing 30 days. Of 26 classified mentions, 58% read bullish, 8% bearish and 34% neutral. Crowd sentiment is a social signal, not investment advice.

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. RedditReddit ingest across the tracked finance subreddits
  4. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
  5. SEC EDGARSEC EDGAR 13F filings
  6. SECSEC fails-to-deliver (CNS) data
  7. House disclosuresU.S. House of Representatives financial disclosures
  8. SEC EDGARValuation computed from SEC EDGAR filings